BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Tempris - ECPv6.17.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Tempris
X-ORIGINAL-URL:https://www.tempris.com
X-WR-CALDESC:Events for Tempris
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261013
DTEND;VALUE=DATE:20261016
DTSTAMP:20260722T141956Z
CREATED:20260722T120430Z
LAST-MODIFIED:20260722T141956Z
UID:17726-1791849600-1792108799@www.tempris.com
SUMMARY:A3P International Congress 2026
DESCRIPTION:Meet Tempris at Booth K02 at the A3P International Congress 2026 in BiarritzThe 37th A3P International Congress will take place on October 13\, 14\, and 15\, 2026 in Biarritz. As it does every year\, the event brings together the entire profession to guide the healthcare industries from the fundamentals to advanced expertise\, while maintaining their competitiveness. \nFor this 2026 edition\, A3P would like to share with you testimonials and insights that fall under the following three major themes: \n\nFacility management\, the foundation of industrial quality and product safety. \n\nSterilization processes\, a fundamental step in the manufacture of sterile products. \n\nCombination product\, at the intersection of pharmaceuticals and medical devices\, subject to a demanding regulatory framework. \nOver these three days\, through 15 conferences\, you will discover concrete examples of how regulatory and environmental challenges are transformed into industrial excellence\, positioning people as an indispensable strategic lever. The sessions will demonstrate how innovation enables us to meet the complex challenges of production to ensure the availability of medicines worldwide. \nYou will participate in workshops (20 workshops available) led by experts and discover an exhibition featuring over than 120 suppliers. This event is a major opportunity to exchange ideas and network with leaders in the pharmaceutical industry. \nThe event will feature the active participation of health authorities\, ANSM\, and the contribution of notified bodies such as GMED\, TÜV\, and BSI. These organizations will address\, in particular\, the challenges of Article 117 of Regulation 2017/745. This gathering is a major opportunity to engage with experts. It reaffirms that people are the indispensable strategic lever of our industry. Join us for these three days of technical and scientific high-level discussions. We look forward to sharing these moments of expertise and network with you in a consistently friendly atmosphere. It is the A3P’s historic legacy that\, year after year\, builds its reputation.
URL:https://www.tempris.com/tempris-event/a3p-international-congress-2026/
LOCATION:Bellevue Convention Center\, Pl. Bellevue\, Biarritz\, 64200\, France
ATTACH;FMTTYPE=image/webp:https://www.tempris.com/wp-content/uploads/2026/07/A3P-International-Congress-2026-Meet-Tempris.webp
ORGANIZER;CN="A3P":MAILTO:info@a3pservices.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261013
DTEND;VALUE=DATE:20261016
DTSTAMP:20260811T145809Z
CREATED:20260811T142024Z
LAST-MODIFIED:20260811T145809Z
UID:18271-1791849600-1792108799@www.tempris.com
SUMMARY:Lyophilization 2026 - Includes Workshop at GEA
DESCRIPTION:Lyophilization 2026Opportunities and Challenges for the Pharmaceutical Industry[ This seminar will be conducted in English. ] \nMeet Tempris at the Lyophilization 2026 Seminar in CologneECA Academy Course No. 22589\nThis course is part of the GMP Certification Programme “ECA Certified Pharmaceutical Engineer” \nTarget GroupObjectivesBackgroundTarget GroupThis conference addresses specialists and executives working in the fields of pharmaceutical manufacture\, research and development and quality control\, as well as engineers\, project/facility engineers\, especially those involved in the implementation of new monitoring methods for controlled nucleation\, risk-based scale-up models and process technology for freeze drying processes. The conference is also of interest for participants working in the areas of container development and manufacturing process/packaging.ObjectivesTake advantage of the opportunity to focus on freeze drying technologies and processes and get a first-hand demonstration of solutions for diverse requirements. Further\, benefit from the workshop where you can get a hands-on experience in freeze drying yourself. In small groups\, you will learn how the freeze drying output is affected by different equipment\, parameter changes\, solvents\, etc.Background\nLyophilization (or freeze drying) is one of the most exciting technologies in the pharmaceutical industry\, although it is a very old process for the preservation of unstable materials. Trends are growing towards using non-aqueous Systems. \nAdditionally\, Process Analytical Technology (PAT) / RTRT (Real Time Release Testing\, Annex 17 of the EU GMP Guide) systems for in-line process monitoring are used to control and determine critical processing parameters. PAT plays also an important role in continuous lyophilization processes. According to ICH´s new guideline Q13 “continuous manufacturing (CM) has potential for improving the efficiency\, agility\, and flexibility of drug substance and drug product manufacturing”. Regulatory agencies have seen more companies engaged in the development and implementation of CM in recent years than in the past. \nModern QbD (Quality by Design) development following ICH Q8\, Q9 and Q10 is based on the objective to design a lyophilization cycle applying a systematic and scientific approach instead of trial and error. Sufficient process understanding is essential to achieve a robust production process and efficient handling of post-approval changes (life cycle management according to ICH Q12) of a freeze drying process. \nThere is an increasing trend in aseptically produced lyophilized products\, including peptides and proteins. Owing to the nature of these biological products\, the lyo-cycle is more complicated and\, in most cases\, even longer than for other medicinal products. \nThe utility of lyophilization goes far beyond the vial. Principles of low temperature\, low pressure can be applied to stabilize substances ranging from high potent APIs\, novel medical devices\, biologics and nanomaterials\, freeze drying offers multiple opportunities.
URL:https://www.tempris.com/tempris-event/eca-academy-lyophilization-2026/
LOCATION:Mercure Hotel Cologne West\, Horbeller Strasse 1\, Cologne\, Nordrhein-Westfalen\, 50858\, Germany
CATEGORIES:Seminars,Workshops
ATTACH;FMTTYPE=image/webp:https://www.tempris.com/wp-content/uploads/2026/08/Meet-Tempris-at-ECA-Academy-Lyophilization-2026.webp
ORGANIZER;CN="Concept Heidelberg":MAILTO:info@concept-heidelberg.de
END:VEVENT
END:VCALENDAR